CPO_Abeta17-21P is a apoE/Abeta interaction inhibitor with an IC50 of 1.02 nM. CPO_Abeta17-21P significantly inhibits ApoE4-mediated aggregation of Abeta40 and Abeta42. CPO_Abeta17-21P significantly improves cognitive function and comprehensively alleviates Alzheimers disease (AD)-related pathologies in mouse models. CPO_Abeta17-21P is applicable to the research of AD[1].
Molekulargewicht:
703.83
Formel:
C37H49N7O7
Anwendungsbeschreibung:
MCE Product type: Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
